NCT06537414 · Interventional trial
A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)
Overall registry status Active not recruiting
Phase 2
Conditions Chronic Hepatitis B Virus Infection, Hepatitis B
Delaware Valley sites
- GSK Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory